Further studies are needed to better understand links between these conditions, but it seems likely that there is overlap between carrier status for JEB and a diagnosis of AI or ERED when they result from heterozygous COL17A1 pathogenic variants. This evidence concerns the gene COL17A1 and epithelial recurrent erosion dystrophy.